World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
52
Citations
8488
World Ranking
4083
National Ranking
359

Antonella Folgori publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Antonella Folgori sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 128 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Antonella Folgori D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Antonella Folgori sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 52 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Antonella Folgori is affiliated with the University of Oxford in the United Kingdom. Their research spans multiple fields, primarily focusing on Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. Within these areas, their subfields of study include Infectious Diseases, Immunology, Molecular Biology, Genetics, and Hepatology.

Their work addresses a range of scientific topics, notably:

  • SARS-CoV-2 and COVID-19 Research
  • Immunotherapy and Immune Responses
  • Vaccines and immunoinformatics approaches
  • Virus-based gene therapy research
  • Hepatitis C virus research
  • Viral gastroenteritis research and epidemiology
  • Immune Cell Function and Interaction

Antonella Folgori has contributed to several recent scientific papers, including:

  • "Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection," 2021, published in New England Journal of Medicine
  • "New viral vectors for infectious diseases and cancer," 2020, published in Seminars in Immunology
  • "A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability," 2020, published in Cancer Research
  • "MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans," 2020, published in Science Translational Medicine
  • "GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults," 2021, published in Science Translational Medicine

Their frequent co-authors include Stefania Capone, Stefano Colloca, Stefano Milleri, Roberto Camerini, and Alessandra M. Contino.

Regular publication venues for their work include bioRxiv (Cold Spring Harbor Laboratory), npj Vaccines, Science Translational Medicine, New England Journal of Medicine, and Seminars in Immunology.

Best Publications

  • Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man

    Eleanor Barnes;Eleanor Barnes;Antonella Folgori;Stefania Capone;Leo Swadling

  • Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

    Daphne A Stanley;Anna N Honko;Anna N Honko;Clement Asiedu;John C Trefry

  • A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.

    Antonella Folgori;Stefania Capone;Lionello Ruggeri;Annalisa Meola

  • A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.

    Leo Swadling;Stefania Capone;Richard D. Antrobus;Anthony Brown

  • A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera.

    A. Folgori;R. Tafi;A. Meola;F. Felici

  • Protective CD8 + T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

    Katie J Ewer;Geraldine A O'Hara;Christopher J A Duncan;Katharine A Collins

  • Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species

    Stefano Colloca;Eleanor Barnes;Antonella Folgori;Virginia Ammendola

  • A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

    Katie Ewer;Tommy Rampling;Navin Venkatraman;Georgina Bowyer

  • Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector

    Geraldine A. O’Hara;Christopher J. A. Duncan;Katie J. Ewer;Katharine A. Collins

  • Prime-boost vectored malaria vaccines: progress and prospects.

    Adrian V S Hill;Arturo Reyes-Sandoval;Geraldine O'Hara;Katie Ewer

  • Mimicking of discontinuous epitopes by phage-displayed peptides, II. Selection of clones recognized by a protective monoclonal antibody against the Bordetella pertussis toxin from phage peptide libraries

    Franco Felici;Alessandra Luzzago;Antonella Folgori;Riccardo Cortese

  • Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer

    Silvia Zucchelli;Stefania Capone;Elena Fattori;Antonella Folgori

  • Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics.

    Armelle Phalipon;Antonella Folgori;Josette Arondel;Giuseppe Sgaramella

  • IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection.

    Heiyoung Park;Elisavet Serti;Onyinyechi Eke;Brian Muchmore

  • Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection

    Kimberly Page;Michael T Melia;Rebecca T Veenhuis;Matthew Winter

  • Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

    C A Green;E Scarselli;C J Sande;A J Thompson

  • Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector Immunization

    Kylie M. Quinn;Andreia Da Costa;Ayako Yamamoto;Dana Berry

  • CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut.

    Fergusson;M H Hühn;L Swadling;L J Walker;L J Walker

  • A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaques

    Stefania Capone;Annalisa Meola;Bruno Bruni Ercole;Alessandra Vitelli

  • MAIT cell activation augments adenovirus vector vaccine immunogenicity.

    Nicholas M. Provine;Ali Amini;Lucy C. Garner;Alexandra J. Spencer

  • Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance

    E Spada;A Mele;A Berton;L Ruggeri

Frequent Co-Authors

Alfredo Nicosia
Alfredo Nicosia University of Naples Federico II
Riccardo Cortese
Riccardo Cortese Schering-Plough
Paul Klenerman
Paul Klenerman University of Oxford
Eleanor Barnes
Eleanor Barnes University of Oxford
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Maria Rosaria Capobianchi
Maria Rosaria Capobianchi National Institutes of Health
Andrew J. Leigh Brown
Andrew J. Leigh Brown University of Edinburgh
Alfonso Mele
Alfonso Mele Istituto Superiore di Sanità
Evan W. Newell
Evan W. Newell Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare roles, many of which can be enhanced by pursuing advanced nursing degrees. For those interested in mental health, exploring the cheapest online pmhnp programs offers an affordable pathway to becoming a Psychiatric-Mental Health Nurse Practitioner, a role that frequently intersects with immunological research in neuroimmune disorders.

Nurses aiming for leadership and specialized clinical roles often consider a Doctor of Nursing Practice (DNP). Understanding how much do dnps make nationally can help prospective students assess the return on investment and plan their educational paths accordingly.

If you are a Family Nurse Practitioner (FNP) looking to specialize further, transitioning through acnp programs is a strategic move. Acute Care Nurse Practitioners work closely with immunocompromised patients, showcasing the relevance of immunology in acute clinical settings.

For registered nurses eager to advance quickly, the accelerated rn to np programs provide a streamlined route to becoming a Nurse Practitioner. These programs cater to professionals wanting to deepen their understanding of immunology-related conditions while advancing their careers.

Best Scientists Citing Antonella Folgori

Trending Scientists

Recently Published Articles